Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Idiopathic intracranial hypertension wikipedia , lookup
Eyeglass prescription wikipedia , lookup
Mitochondrial optic neuropathies wikipedia , lookup
Visual impairment wikipedia , lookup
Fundus photography wikipedia , lookup
Vision therapy wikipedia , lookup
Blast-related ocular trauma wikipedia , lookup
Diabetic retinopathy wikipedia , lookup
Retina Imaging Conference Brett Mueller, D.O., Ph.D. 2/11/2016 University of Louisville Department of Ophthalmology and Visual Sciences Patient Presentation CC: Decreased Vision Left Eye HPI: 59 yo WM presents w/ gradual, painless blurry vision OS that has been getting worse for the past several months. Pt denies any history of trauma, HAs, or jaw claudication. History POHx: none PMHx: Hypertension and controlled on medical management FAMHx: none ROS: none MEDS: Metoprolol, aspirin, and a statin ALLERGIES: none Exam 18 20/20 (+1.25 sph) VA TP 20/CF 1 ft (+1.75 sph) 3→2 P 20 3→2 NO RAPD EOM: full OU Exam OD OS LIDS/LASHES WNL WNL CONJ WNL WNL CORNEA WNL WNL IRIS WNL WNL LENS 1+NS 1+NS Fundus Photos OD OS IR Photos OD OS FAF Photos OD OS OCT OD Macula OS Macula OCT OS Below the Fovea OS Through the Nevus FA Early Venous Phase 00:12:00 Late Phase 02:00:00 FA/ICG Summary 59 y/o WM with decreased vision OS. Examination and FA reveal a choroidal neovascular membrane w/ a concomitant choroidal nevus DDx: Choroidal neovascular membrane Idiopathic ? Nevus ? PLAN: Avastin injection with 1 month f/u Exam s/p 2 Avastin Injections 16 20/20 (+1.25 sph) VA TP 20/300 (+1.75 sph) 3→2 P 16 3→2 no RAPD EOM: full OU OCT OS OCT OS Below the Fovea OS Through the Nevus Cause of the CNVM Is it due to the choroidal nevus? Or is it an idiopathic CNVM? Complications of Choroidal Nevi Numerous studies postulate that the prevalence of choroidal nevi in the general population is anywhere from 0.2% - 30% Most use 6.5% as the incidence of nevi in the general population Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol. 1998 May;116(5):645-50. PubMed PMID: 9596501 Naumann GOHHellner KNaumann LR Pigmented nevi of the choroid: clinical study of secondary changes in the overlying tissues. Trans Am Acad Ophthalmol Otolaryngol.1971;75110- 123 Complications of Choroidal Nevi Decreased visual acuity attributable to Serous foveal detachment Photoreceptor degeneration CNVM Blue Mountains Eye Study: None had complications associated with vision loss Gonder JR, Augsburger JJ, McCarthy EF, Shields JA. Visual loss associated with choroidal nevi. Ophthalmology. 1982 Aug;89(8):961-5. PubMed PMID: 6182515. Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol. 1998 May;116(5):645-50. PubMed PMID: 9596501 Complications of Choroidal Nevi 22 of 206 patients (11%) with choroidal lesions had decreased VA attributable to : Serous foveal detachment (50%) Photoreceptor degeneration (42%) CNVM (8%) 322 eyes with giant choroidal nevi, 2.2% had decreased vision Gonder JR, Augsburger JJ, McCarthy EF, Shields JA. Visual loss associated with choroidal nevi. Ophthalmology. 1982 Aug;89(8):961-5. PubMed PMID: 6182515. Li HK, Shields CL, Mashayekhi A, Randolph JD, Bailey T, Burnbaum J, Shields JA. Giant choroidal nevus clinical features and natural course in 322 cases. Ophthalmology. 2010 Feb;117(2):324-33. doi: 10.1016/j.ophtha.2009.07.006. Epub 2009 Dec 6. PubMed PMID: 19969359. Complications of Choroidal Nevi Choroidal Nevus Risk Factors for Vision loss Nevus proximity to foveola (0 mm vs > 0 mm): RR = 36.46 Subretinal fluid (> 3 to 6 mm vs none): RR = 498.33 RPE detachment (present vs absent):RR = 33.01 CNVM (present vs absent): RR = 98.72 Li HK, Shields CL, Mashayekhi A, Randolph JD, Bailey T, Burnbaum J, Shields JA. Giant choroidal nevus clinical features and natural course in 322 cases. Ophthalmology. 2010 Feb;117(2):324-33. doi: 10.1016/j.ophtha.2009.07.006. Epub 2009 Dec 6. PubMed PMID: 19969359. Shields CL, Furuta M, Mashayekhi A, Berman EL, Zahler JD, Hoberman DM, Dinh DH, Shields JA. Visual acuity in 3422 consecutive eyes with choroidal nevus. Arch Ophthalmol. 2007 Nov;125(11):1501-7. PubMed PMID: 17998511. Why the Difference Between the Studies In the Blue Mountains Eye Study, the average diameter for the nevus was between 1-2mm, with 1.5% of them being over 4mm Wills Eye 3,000+ patients with choroidal nevi have an average diameter of 5.1-5.7mm Conclusion Is the CNVM secondary to the choroidal nevus? Or is it just an idiopathic CNVM, and the choroidal nevus is just an innocent bystander Choroidal nevi can cause decreased VA Proximity to the fovea Subretinal fluid RPE detachment CNVM THANK YOU References 1. 2. 3. 4. Retina and Vitreous, BCSC Ophthalmic Pathology and Intraocular Tumors, BCSC American Academy of Ophthalmology eye wiki website on idiopathic CNVMs Krypton laser photocoaguluation for idiopathic neovascular lesions: results of a randomized clinical trial. Photocoagulation Study Group. Arch Ophthalmol. 1990; 108: 832-837 5. Persistent and recurrent NV after krypton laser photocoagulation for NV lesion of ocular histoplasmosis. Macular Photocoagulation Study Group. Arch Ophthalmol. 1989; 107:344-352 6. Kanski’s Clinical Ophthalmology A systemic Approach, Eighth Edition. Brad Bowling 7. Gonder JR, Augsburger JJ, McCarthy EF, Shields JA. Visual loss associated with choroidal nevi. Ophthalmology. 1982 Aug;89(8):961-5. PubMed PMID: 6182515. 8. D.G. Callanan, M.L. Lewis, S.F. Byrne, J.D.M. Gass Choroidal neovascularization associated with choroidal nevi Arch Ophthalmol, 111 (1993), pp. 789–794 9. Gass JD Problems in the differential diagnosis of choroidal nevi and malignant melanoma: XXXIII Edward Jackson Memorial lecture. Trans Am Acad Ophthalmol Otolaryngol.1977;8319- 48 10. Ganley JPComstock GW Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol. 1973;7619- 25 11. Naumann G Pigmented nevi of the choroid and ciliary bodies: a clinical and histopathological study. Adv Ophthalmol. 1970;23187- 272 12. Hale PNAllen RAStraatsma BR Benign melanomas (nevi) of the choroid and ciliary body. Arch Ophthalmol. 1965;74532- 538 13. Wilder HC Intraocular tumors in soldiers: World War II. Mil Surg. 1946;99459- 490 14. Lang GKDaumann FJ Peripheral fundus changes in subjects with healthy eyes (pilots). Klin Monatsbl Augenheilkd. 1982;181493- 495 Link to Article 15. Albers EC Benign melanomas of the choroid and their malignant transformation. Am J Ophthalmol. 1940;23779- 783 16. Albert DMRobinson NLFulton AB et al. Epidemiological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin.1980;2071- 92 17. Albert DMSearl SSForget BLavin PTKirkwood JNordlund JJ Uveal findings in patients with cutaneous melanoma. Am J Ophthalmol. 1983;95474- 479 18. Rodriguez Sains RS Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology. 1986;93661- 665 19. Smith REGanley JP Ophthalmic survey of a community, I: abnormalities of the ocular fundus. Am J Ophthalmol. 1972;741126- 1130 20. Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol. 1998 May;116(5):645-50. PubMed PMID: 9596501 Idiopathic CNVM Is a disease of exclusion that can be made after all other causes associated with CNV have been ruled out: Angioid streaks High myopia AMD Chorioretinal inflammatory conditions Tumors Trauma Idiopathic CNVM Some speculate that it could represent POHS w/o the punched-out chorioretinal lesion Other speculate that it could be a variant of AMD w/out drusen or RPE abnormalities Krypton laser photocoaguluation for idiopathic neovascular lesions: results of a randomized clinical trial. Photocoagulation Study Group. Arch Ophthalmol. 1990; 108: 832-837 Persistent and recurrent NV after krypton laser photocoagulation for NV lesion of ocular histoplasmosis. Macular Photocoagulation Study Group. Arch Ophthalmol. 1989; 107:344-352